Wipro Technologies has announced a secure cloud-based "productised" solution called "Wipro Clinical Collaboration Portal", to help its customer base of drug development owners (sponsors), CROs (clinical research organisations), clinical sites and regulators to significantly improve collaboration capabilities for multi-region clinical trials.
Clinical trials for global studies require close collaboration between partners and regulators across multiple regions to conduct multi-region clinical trials effectively and rapidly and
Wipro said the portal platform would reduce the clinical trial cycle time by 20 per cent - 30 per cent by speeding up communication and document exchanges between all the stakeholders – the sponsor organisations, the staff of the CRO along with clinical site coordinators and principal investigators.
"This Portal platform can be leveraged as an enterprise level solution to increase efficiency and lower the cost of clinical operations," it said in a statement.
It said the portal has the capability to better manage all the data required to conduct a clinical trial that makes up the trial master file – which, in the existing clinical trial model, is dominantly paper based in combination with shared folders across geographies.
By enforcing a common standard operating procedure (SOP) across the groups which are involved in clinical trials, the Wipro Clinical Collaboration portal helps them to better adhere to regulatory frameworks such as Good Clinical Practice (GCP) guidelines to avoid any oversight in the trial management process.